{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:28:11Z","timestamp":1786998491116,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRPSG-2025-01-02423"],"award-info":[{"award-number":["IIRPSG-2025-01-02423"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["C1\/23\/117"],"award-info":[{"award-number":["C1\/23\/117"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymeth.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:53:26Z","timestamp":1773075206000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Concurrent quantification of novel cyclometalated iridium-based photosensitizer and 5-fluorouracil using RP-HPLC: Applications in nanoformulation analysis, drug release, and skin permeation studies"],"prefix":"10.1016","volume":"250","author":[{"given":"Pragati Ramesh","family":"Kumbhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhavi Meghraj","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Sumit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inamur Rahaman","family":"Laskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2026.03.002_b0005","unstructured":"W. health Organization, Skin cancer \u2013 IARC, (n.d.). https:\/\/www.iarc.who.int\/cancer-type\/skin-cancer\/ (accessed October 7, 2025)."},{"key":"10.1016\/j.ymeth.2026.03.002_b0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jphotobiol.2016.11.004","article-title":"A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells","volume":"166","author":"Biteghe","year":"2017","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ymeth.2026.03.002_b0015","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/17425247.2024.2392799","article-title":"Exploring the therapeutic modalities of targeted treatment approach for skin carcinoma: cutting-edge strategies and key insights","volume":"21","author":"Desai","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ymeth.2026.03.002_b0020","first-page":"1","article-title":"Nanoparticle-based Combination Therapy for Melanoma","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.ymeth.2026.03.002_b0025","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acsabm.2c00998","article-title":"Rational molecular designing of aggregation-enhanced emission (AEE) active red-emitting iridium(III) complexes: effect of lipophilicity and nanoparticle encapsulation on photodynamic therapy efficacy","volume":"6","author":"Sumit","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ymeth.2026.03.002_b0030","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: mechanisms of resistance and reversal strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.ymeth.2026.03.002_b0035","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1016\/j.arabjc.2020.09.022","article-title":"Systematic development and validation of RP-HPLC method for simultaneous estimation of tamoxifen and sulphoraphane with specific application for nanolipidic formulations","volume":"13","author":"Mangla","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ymeth.2026.03.002_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573412912666160922124552","article-title":"Development and validation of a new HPLC Method for the detection of 5- fluorouracil in mobile phase and in plasma","volume":"14","author":"Hanif","year":"2017","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.ymeth.2026.03.002_b0045","doi-asserted-by":"crossref","first-page":"e5482","DOI":"10.1002\/bmc.5482","article-title":"Retention behaviour of analytes in reversed-phase high-performance liquid chromatography\u2014A review","volume":"37","author":"Ganesh","year":"2023","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ymeth.2026.03.002_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S1984-82502013000100013","article-title":"Development and validation of an HPLC method for the determination of fluorouracil in polymeric nanoparticles","volume":"49","author":"de Mattos","year":"2013","journal-title":"Brazilian J. Pharm. Sci."},{"key":"10.1016\/j.ymeth.2026.03.002_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5582\/ddt.2022.01011","article-title":"Stability of extemporaneously compounded 5-fluorouracil utilizing high performance liquid chromatography","volume":"16","author":"Komm","year":"2022","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.ymeth.2026.03.002_b0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.aca.2006.09.015","article-title":"A comparative study of the performance of acetonitrile and methanol in the multi-linear gradient separation of proteic primary amino acids","volume":"582","author":"Concha-Herrera","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ymeth.2026.03.002_b0065","unstructured":"CHROM TECH, Acetonitrile vs. Methanol for Reverse Phase Chromatography - Chrom Tech, Inc., (n.d.). https:\/\/chromtech.com\/acetonitrile-vs-methanol-for-reverse-phase-chromatography\/ (accessed October 7, 2025)."},{"key":"10.1016\/j.ymeth.2026.03.002_b0070","unstructured":"Food and drug administration, Q2(R1) Validation of Analytical Procedures: Text and Methodology Guidance for Industry, (2005). https:\/\/www.fda.gov\/vaccines-blood-biologics\/guidance-compliance-regulatory-information-biologics\/biologics-guidances (accessed July 31, 2025)."},{"key":"10.1016\/j.ymeth.2026.03.002_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4155\/bio-2021-0212","article-title":"Analytical and Bioanalytical HPLC Method for Simultaneous estimation of 5-Fluorouracil and Sonidegib","volume":"14","author":"Padya","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ymeth.2026.03.002_b0080","unstructured":"Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry, (2015). http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htmand\/orhttp:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm (accessed August 6, 2025)."},{"key":"10.1016\/j.ymeth.2026.03.002_b0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/0122132406291221240819062440","article-title":"Method development and validation of stability-indicating HPLC-UV method for determination of 5 -fluorouracil","volume":"10","author":"Gulati","year":"2024","journal-title":"Curr. Spectrosc. Chromatogr."},{"key":"10.1016\/j.ymeth.2026.03.002_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.202200107","article-title":"Stability indicating validated high-performance liquid chromatography method for simultaneous estimation of chlorin e6 and curcumin in bulk and drug-loaded lipidic nanoformulation","volume":"6","author":"Jain","year":"2023","journal-title":"Sep. Sci. Plus"},{"key":"10.1016\/j.ymeth.2026.03.002_b0095","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.jaad.2023.05.078","article-title":"Response to Pan et al\u2019s \u201cNon-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study,","volume":"89","author":"Barry","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymeth.2026.03.002_b0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157341212798995557","article-title":"Evaluation of stability of 5- fluorouracil under different stress conditions: high performance liquid chromatography and infrared spectroscopic approach","volume":"8","author":"Yadav","year":"2012","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.ymeth.2026.03.002_b0105","article-title":"Optimizing cancer patient care with a robust assay for 5-fluorouracil quantification and in-vitro stability in human blood for therapeutic drug monitoring","volume":"40","author":"Gurjar","year":"2024","journal-title":"Pract. Lab. Med."},{"key":"10.1016\/j.ymeth.2026.03.002_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111898","article-title":"Comparative degradation of 5-fluorouracil in aqueous solution by using H2O2-modified subcritical water, photocatalytic oxidation and electro-Fenton processes","volume":"204","author":"Kulaks\u0131z","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.ymeth.2026.03.002_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.110681","article-title":"Development and validation of RP-HPLC method for simultaneous estimation of 5-fluorouracil and silibinin in corn-derived protein-polysaccharide nanocomplex: forced degradation and mathematical modeling of drug release","volume":"201","author":"Sudhakar Gomte","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.ymeth.2026.03.002_b0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2023.03.004","article-title":"Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies","volume":"186","author":"Waghule","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ymeth.2026.03.002_b0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17425247.2024.2439457","article-title":"Versatility of emulgel in topical drug delivery transforming its expedition from bench to bedside","volume":"22","author":"Kumbhar","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ymeth.2026.03.002_b0130","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1039\/D4AY00814F","article-title":"Determination of 3-acetyl-11-keto-\u03b2-boswellic acid in analytical and biological samples using streamlined and robust RP-HPLC method","volume":"16","author":"Priya","year":"2024","journal-title":"Anal. Methods"},{"key":"10.1016\/j.ymeth.2026.03.002_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105438","article-title":"Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition","volume":"152","author":"Rapalli","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ymeth.2026.03.002_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/jamc\/5522915","article-title":"Development of RP-HPLC method for simultaneous determination of triclabendazole and ivermectin in pharmaceutical suspension dosage form","volume":"2025","author":"Rahman","year":"2025","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.ymeth.2026.03.002_b0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.22159\/ijap.2024v16i3.50276","article-title":"RP-HPLC method development and validation for simultaneous estimation of curcumin and resveratrol in nano-micelle: dual drug dual form simultaneous estimation","volume":"16","author":"Rahaman","year":"2024","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.ymeth.2026.03.002_b0150","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.chroma.2011.02.012","article-title":"Mobile phase effects in reversed-phase liquid chromatography: a comparison of acetonitrile\/water and methanol\/water solvents as studied by molecular simulation","volume":"1218","author":"Rafferty","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ymeth.2026.03.002_b0155","unstructured":"P.G. Hub, Why does Acetonitrile have higher elution strength than methanol?, (2023). https:\/\/www.pharmagrowthhub.com\/post\/why-does-acetonitrile-have-higher-elution-strength-than-methanol (accessed February 3, 2026)."},{"key":"10.1016\/j.ymeth.2026.03.002_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcoa.2024.100135","article-title":"Applications and retention properties of alternative organic mobile phase modifiers in reversed-phase liquid chromatography","volume":"5","author":"Atapattu","year":"2024","journal-title":"J. Chromatogr. Open"},{"key":"10.1016\/j.ymeth.2026.03.002_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2024.100103","article-title":"Sustainable and white HPLC method for simultaneous determination of amlodipine and atorvastatin in film-coated tablet","volume":"8","author":"Tomikj","year":"2024","journal-title":"Green Anal. Chem."},{"key":"10.1016\/j.ymeth.2026.03.002_b0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4103\/0250-474X.59544","article-title":"A stability-indicating RP-HPLC assay method for 5-fluorouracil","volume":"71","author":"Sinha","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ymeth.2026.03.002_b0175","unstructured":"BioPharm Internatinal.com, Challenges in Analytical Method Development and Validation | BioPharm International, (2014). https:\/\/www.biopharminternational.com\/view\/challenges-analytical-method-development-and-validation (accessed February 3, 2026)."},{"key":"10.1016\/j.ymeth.2026.03.002_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4068\/cmj.2025.61.1.19","article-title":"Biopharmaceutical analysis by HPLC: practices and challenges","volume":"61","author":"Mahdi","year":"2025","journal-title":"Chonnam Med. J."},{"key":"10.1016\/j.ymeth.2026.03.002_b0185","unstructured":"Eureka by patsnap, Optimize HPLC Method Validations for Regulatory Compliance, (2025). https:\/\/eureka.patsnap.com\/report-optimize-hplc-method-validations-for-regulatory-compliance (accessed February 3, 2026)."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:54:10Z","timestamp":1778583250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S1046202326000502"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.03.002","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent quantification of novel cyclometalated iridium-based photosensitizer and 5-fluorouracil using RP-HPLC: Applications in nanoformulation analysis, drug release, and skin permeation studies","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}